Related Experiment Video

Updated: Aug 7, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

TRAIL and Bortezomib: killing cancer with two stones

Muhammad Zahid Qureshi1, Mirna Azalea Romero, Rukset Attar

  • 1Department of Chemistry, GCU Lahore, Lahore, Pakistan

Asian Pacific Journal of Cancer Prevention : APJCP
|March 7, 2015
PubMed

Insights

Understanding cancer development requires knowledge of tumor suppressors and oncogenes. Pharmacological proteasome inhibition may enhance TRAIL-induced apoptosis in cancer cells, aiding treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer genomics and proteomics have advanced, revealing insights into cancer development, progression, and survival.
  • Loss of apoptosis is a critical hallmark of cancer, and restoring it is a key therapeutic goal.
  • Understanding the balance of pro-apoptotic and anti-apoptotic proteins is crucial for inducing cancer cell death.

Purpose of the Study:

  • To explore the potential of pharmacological proteasome inhibition in enhancing TRAIL-induced apoptosis in cancer cells.
  • To highlight the importance of understanding tumor suppressors, oncogenes, and apoptosis-regulating proteins for cancer therapy.
  • To bridge the gap between basic research findings and clinical applications in cancer treatment.

Main Methods:

  • Utilizing advanced platforms like microarrays and high-throughput resequencing to analyze cancer determinants.
  • Investigating the modulation of pro-apoptotic and anti-apoptotic protein balance.
  • Examining the effects of pharmacological proteasome inhibition on cancer cell apoptosis.

Main Results:

  • Pharmacological proteasome inhibition shows promise in improving TRAIL-induced apoptosis in cancer cells.
  • Enhanced knowledge of key cancer-related proteins can inform therapeutic strategies.
  • The study emphasizes the need for a deeper understanding of carcinogenesis, metastasis, and therapeutic resistance.

Conclusions:

  • Modulating apoptosis is essential for overcoming cancer resistance.
  • Pharmacological proteasome inhibition is a potential strategy to enhance cancer cell apoptosis.
  • Translating benchtop findings on cancer-related proteins to clinical practice is vital for improving patient outcomes.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...